LONDON - Dr. Martens plc, the iconic British footwear brand, has confirmed the appointment of Ije Nwokorie as its new Chief Executive Officer, effective from January 6, 2025. The announcement made today follows the company's initial notice on April 16, 2024, regarding the planned leadership transition.
Ije Nwokorie will be taking over the reins from Kenny Wilson, who is set to step down from the Board on the same day his successor assumes the role. To ensure a seamless transition, Wilson will continue to be available to Nwokorie and the Global Leadership Team until March 31, 2025.
The company has adhered to its statutory obligations under section 430(2B) of the Companies Act 2006 by disclosing the details of Wilson's exit arrangements, which will be accessible on the company's corporate website.
Dr. Martens, a brand synonymous with counterculture and individualism, has been a fixture in the footwear industry since its inception in 1960. Known for its durable and tough boots, the brand has evolved beyond its working-class origins to become a symbol of empowerment for wearers around the globe.
This leadership change comes as Dr. Martens continues to uphold its position as a constituent of the FTSE 250 index, reflecting its standing within the UK's mid-cap equity market.
The company's adherence to the UK Listing Rules has been noted, with confirmation that no additional information is required to be disclosed under paragraph 9.6.13 of the rules.
The news of this executive transition is based on a press release statement issued by Dr. Martens plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.